← Back to TCM Global · All articles
2026-11-04
The China International Import Expo (CIIE) in Shanghai, November 5-10, 2026, condenses hundreds of health-product exhibitors into six days, and the buyers who extract the most value are those who arrive with a scored shortlist, pre-booked meetings, and clear MOQ targets rather than treating the show as browsing. For ginseng and TCM herbal products specifically, CIIE has become a practical sourcing checkpoint: Chinese suppliers debut winter-tonic lines there, and international buyers use it to compare formats side by side before committing to samples or audits. This article distills the takeaways that matter for B2B ginseng buyers, whether you attend in person or follow the show remotely.
CIIE is positioned as an import-focused expo, so exhibitors actively court overseas buyers — unlike general trade fairs where export may be secondary. For ginseng, the show typically concentrates three supplier groups in one hall circuit: origin growers and processors from Jilin and Changbai Mountain regions, OEM/ODM manufacturers offering private-label formats, and trading companies with multi-category herbal portfolios.
The practical value is comparison density. In two days of walking you can taste, touch, and price ginseng honey pastes, tea granules, jelly sticks, RTD drinks, and capsule products from 10-20 manufacturers — a comparison that would otherwise take months of email exchanges. Industry reports on Chinese health-product exports consistently note that Q4 trade shows feed directly into next-year contract cycles, making CIIE an ideal input for your 2027 ginseng sourcing strategy planning.
Preparation separates productive buyers from brochure collectors:
Use a consistent rubric so comparisons are fair. Focus on four dimensions:
| Dimension | What to Check | Red Flags |
|---|---|---|
| Factory reality | Photos/videos of production lines, staff count, in-house vs outsourced steps | Catalog-only claims, refusal to show facility |
| Quality system | COAs, third-party lab access, batch traceability | No ginsenoside specification per batch |
| Export track record | Markets served, registration experience (EU, GCC, FDA) | Zero experience with your region's import rules |
| Commercial terms | MOQ, payment terms, lead time, private-label support | Vague quotes, unwillingness to put MOQ in writing |
Ask every supplier the same five questions: What is your annual ginseng output? Which markets do you currently export to? Can you share a recent third-party COA? What is your MOQ for private label? What is your standard lead time in peak season? Consistent answers across 15+ suppliers give you a real market map. For deeper diligence afterward, follow the ginseng supplier audit checklist and learn to read a third-party lab report for ginseng before wiring any deposit.
Within one week, send each shortlisted supplier a summary email confirming what was discussed, requested documents, and sample specs. Within three weeks, complete document review and lab testing of show samples. Within six weeks, hold video calls with the top 3-5 candidates. Industry surveys of trade-fair conversion consistently show that buyers who follow up within 7-10 days are 2-3 times more likely to reach a trial order than those who wait a month. A typical CIIE cycle produces 3-5 qualified suppliers, 1-2 trial orders, and — for well-prepared buyers — a signed 2027 framework agreement.
Yes. Most exhibitors offer virtual meetings and sample shipping, and many Chinese suppliers list full specs online. In-person attendance adds taste testing and faster rapport, but a disciplined remote follow-up on the exhibitor catalog can achieve a comparable shortlist.
Typical private-label MOQs at the show range from 500-3,000 units for packaged formats (pastes, teas, sticks) and 100-300 kg for bulk extracts or powder. Traders may accept smaller first orders at a 10-15% price premium.
Yes — it is one of the best. Dedicated ginseng OEM manufacturers for tea granules, honey pastes, and gummies exhibit alongside origin processors, letting you compare development capabilities and tooling costs in a single trip.